Accelrys Q2 Sales Dip, But Profit Rises | GenomeWeb
NEW YORK (GenomeWeb News) - Accelrys yesterday said fiscal second-quarter 2008 revenues fell around 2 percent as R&D spending dropped around 13 percent and profit shot up 75 percent.
Total receipts for the three months ended Sept. 30, 2007, dipped to $19.7 million from $20.2 million year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.